Do you offer adjuvant osimertinib to EGFR exon 19 deleted patients with T2N0 NSCLC treated with definitive SBRT?  

I.e. based on the findings of ADAURA in surgically managed patients.



Answer from: Radiation Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution